In this presentation, Dr. Greenlee reviews current evidence-based recommendations for the management of diabetic kidney disease, with a focus on appropriate use of urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate… […]
Keyword: dm
Case Discussion: Behavioral Barriers | June 11, 2026
In this presentation, Dr. Greenlee explores behavioral barriers that can interfere with effective diabetes self-management through a live case presentation and discussion, including challenges with medication adherence, dietary modification, and… […]
Read More… from Case Discussion: Behavioral Barriers | June 11, 2026
Lipoprotein (a) – You HAVE to Know About This | May 14, 2026
In this presentation, Dr. Saef explains lipoprotein(a), how to measure it, and its role as an independent risk factor for coronary artery disease. Furthermore, he identifies at-risk patients, reviews current… […]
Read More… from Lipoprotein (a) – You HAVE to Know About This | May 14, 2026
Diabetes Distress: What YOU can do to Help | April 9, 2026
In this presentation, Dr. Greenlee defines diabetes distress and explains its impact on individuals with diabetes and overall disease management. Furthermore, she discusses why addressing diabetes distress is important and outlines practical… […]
Read More… from Diabetes Distress: What YOU can do to Help | April 9, 2026
Maturity Onset Diabetes in the Young (MODY) | March 19, 2026
In this presentation, Dr. Greenlee provides an overview of Maturity Onset Diabetes in the Young (MODY), including its genetic basis, prevalence, and common patterns of misdiagnosis. She also discusses key clinical features, major subtypes,… […]
Read More… from Maturity Onset Diabetes in the Young (MODY) | March 19, 2026
Pancreatic Diabetes: Part 2 | February 12, 2026
In this presentation, Dr. Greenlee reviews cystic fibrosis related diabetes (CFRD) and pancreatic cancer related diabetes, highlighting their distinct pathophysiology, clinical features, and management considerations. Particular attention is given to postprandial hyperglycemia in CFRD, the paraneoplastic nature… […]
Read More… from Pancreatic Diabetes: Part 2 | February 12, 2026
Clinical Decision-Making for Insulin Pump Use | January 8, 2026
In this presentation, Dr. Carol Greenlee, MD, and Robin John, RPh, review key clinical considerations for insulin pump use in people with type 2 diabetes, focusing on a complex case with very… […]
Read More… from Clinical Decision-Making for Insulin Pump Use | January 8, 2026
Diabetes and HCV | December 11, 2025
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV… […]
Diabetes and HCV | December 3, 2025
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV… […]
Diagnosing Diabetes: Next Steps – Approach after Diagnosis | March 13, 2025
In this presentation, Dr. Carol Greenlee, MD, explores how a supportive, hopeful, and collaborative approach can significantly impact long-term self-management and health outcomes of those receiving a diabetes diagnosis. Furthermore,… […]
Read More… from Diagnosing Diabetes: Next Steps – Approach after Diagnosis | March 13, 2025
